诊断血清盘

您可以选择现货供应或根据要求定制血清盘：抑制血清盘、干扰血清盘、抗凝剂血清盘、质控血清盘、血清转换板以及标准化血清盘。

血清转换盘

我们的血清转换盘是从未加工的血浆开发的，通过在感染演变过程中和随之而来的免疫反应采集个体血浆来实现的。我们的血清转换盘包含明确的感染标志物，并包含广泛的样本测试数据，可用于比较和分析。

我们的血清转换盘旨在被诊断制造商和研究人员在分析开发、评估、故障排除以及IgM/IgG抗体测试系统和方法的后续监测中使用。此外，这些血清盘还可作为诊断灵敏度的验证工具，用于测量分析灵敏度、确定临界值或研究特定感染的体液免疫反应。

在这里，您可以找到多种具有高质量数据集产品，帮助您评估检测方法：

Order no.	Old profile diagnostics no.	Marker	Panel member	Member volumes	Time period for donation
SCP-CMV-001	RP-003	CMV	15	0.5 mL	Mar 94 – Jul 94
SCP-CMV-002	RP-019	CMV	25	0.5 mL	Feb 99 - May 99
SCP-CMV-005		CMV	6	0.5 mL	Nov 10 – Dec 10
SCP-CMV-006		CMV	24	0.5 mL	Feb 11 – Jun 11
SCP-CMV-007		CMV	20	0.5 mL	Apr 12 – Aug 12
SCP-EBV-001		EBV	27	0.5 mL	Oct 12 – Feb 13
SCP-EBV-002		EBV	25	0.5 mL	Apr 13 - Nov 13
SCP-HAV-001	RP-004	HAV	15	0.3 mL	Sep 94 – Nov 94
SCP-HAV-002	RP-013	HAV	15	0.3 mL	Apr 96 – Oct 96
SCP-HBV-001	RP-009	HBV	20	0.5 mL	Jul 95 – Feb 96
SCP-HBV-002	RP-016	HBV	20	0.5 mL	Jul 96 – Dec 96
SCP-HBV-003	RP-028	HBV	9	0.5 mL	Oct 96 – Nov 96
SCP-HBV-004	RP-017	HBV	30	0.5 mL	Jan 97 – Jul 97
SCP-HBV-005	RP-027	HBV	7	0.5 mL	Nov 97 – Jan 98
SCP-HBV-006	RP-037	HBV	4	0.5 mL	Sep 98
SCP-HBV-007	RP-020	HBV	3	0.5 mL	Jan 99 - Feb 99
SCP-HCV-001	RP-006	HCV	20	0.5 mL	Jul 90 – Dec 91
SCP-HCV(Ag)-003		HCV Ag only	5	1.0 mL	Sep 13 - Oct 13
SCP-HCV-004		HCV	4	1.0 mL	Aug 12 - Sep 12
SCP-HCV(Ag)-005		HCV Ag only	7	1.0 mL	Jul 12 - Aug 12
SCP-HCV(Ag)-006		HCV Ag only	6	1.0 mL	Jan 14
SCP-HCV(Ag)-007		HCV Ag only	18	1.0 mL	Jul 12 - Nov 12
SCP-HCV(Ag)-008		HCV Ag only	11	1.0 mL	Dec 12 - Jan 13
SCP-HCV-009	RP-038	HCV	8	0.5 mL	Oct 00 – Dec 00
SCP-HCV-010		HCV	9	1.0 mL	Feb 12 - Mar 12
SCP-HCV-011		HCV	5	1.0 mL	Mar 12 - Apr 12
SCP-HCV-012		HCV	4	1.0 mL	Oct 13
SCP-HEV-001a		HEV	8	1.0 mL	Jun 11 – Aug 11
SCP-HEV-001b		HEV	8	1.5 mL	Jun 11 – Aug 11
SCP-HEV-002a		HEV	8	1.0 mL	Jun 11 – Sep 11
SCP-HEV-002b		HEV	8	1.5 mL	Jun 11 – Sep 11
SCP-HEV-003a		HEV	12	1.0 mL	Jun 11 – Oct 11
SCP-HEV-003b		HEV	12	1.5 mL	Jun 11 – Oct 11
SCP-HEV-004a		HEV	11	1.0 mL	Aug 11 – Sep 11
SCP-HEV-004b		HEV	11	1.5 mL	Aug 11 – Sep 11
SCP-HEV-005a		HEV	20	1.0 mL	Jul 11 – Dec 11
SCP-HEV-005b		HEV	20	1.5 mL	Jul 11 – Dec 11
SCP-HEV-006a		HEV	23	1.0 mL	Jul 11 – Jan 12
SCP-HEV-006b		HEV	23	1.5 mL	Jul 11 – Jan 12
SCP-HEV-007a		HEV	17	1.0 mL	Aug 11 – Jan 12
SCP-HEV-007b		HEV	17	1.5 mL	Aug 11 – Jan 12
SCP-HEV-008a		HEV	11	1.0 mL	Aug 11 – Dec 11
SCP-HEV-008b		HEV	11	1.5 mL	Aug 11 – Dec 11
SCP-HEV-009a		HEV	9	1.0 mL	Aug 11 – Dec 11
SCP-HEV-009b		HEV	9	1.5 mL	Aug 11 – Dec 11
SCP-HIV1-002	RP-002	HIV 1	20	1.0 mL	May 88 – Sep 88
SCP-HIV1-003	RP-007	HIV 1	7	1.0 mL	Apr 94 - Jun 94
SCP-HIV1-004	RP-034	HIV 1	7	1.0 mL	Apr 97 - Jun 97
SCP-HIV1-005	RP-018	HIV 1	25	1.0 mL	Jan 98 - Jun 98
SCP-HIV1-006	RP-029	HIV 1	17	1.0 mL	Feb 99 - May 99
SCP-HIV1-007	RP-033	HIV 1	9	1.0 mL	May 00 - Jun 00
SCP-HIV1-008		HIV 1	8	1.0 mL	Aug 11 - Oct 11
SCP-MEA-001	RP-005	Measles	15	0.5 mL	May 94 - Jul 94
SCP-RUB-001	RP-001	Rubella	15	1.0 mL	Dec 92 - Jan 93
SCP-RUB-002	RP-014	Rubella	13	1.0 mL	Apr 93 - May 93
SCP-RUB-003	RP-011	Rubella	20	1.0 mL	Mar 96 - Jun 96
SCP-RUB-004		Rubella	15	0.5 mL	Mar 15 - May 15
SCP-PARVO-001		Parvo B19		0.2 mL
SCP-TP-001		Treponema Pallidum (Syphilis)		0.5 mL	Jan 24 – Jun 24

抗凝剂血清盘

抗凝剂血清盘用于揭示各种抗凝剂对检测结果的潜在影响。可从健康供体中获得5个或10个样本的抗凝剂血清盘。我们也很乐意应客户要求接受任何抗凝剂血清盘。所有供体均通过 CE 认证的测试，抗 HIV、抗HCV 和乙肝表面抗原的检测结果均为阴性/无反应。

当然，我们也为您进行样品储存稳定性研究–请使用我们的服务来完成您的项目。

Order no.	Product description	Volumes
MSS-005 (5 sample sets) MSS-010 (10 sample sets) or MSS-XXX (customized)	Matched sets small Serum Sodium citrate K2EDTA Lithium heparin	1.0 mL
MSS-005 (5 sample sets) MSS-010 (10 sample sets) or MSS-XXX (customized)	Matched sets large* Serum Sodium citrate K2EDTA K3EDTA Sodium heparin Lithium heparin ACD-B CPDA K-oxalate / Na-fluoride	1.0 mL

* or contract production

CS 筛选测试盘

CS筛查测试盘用于满足2017/746（IVDR）下D类设备的要求。有关IVDR的更多信息可以在这里找到。

血清转换检测板始于阴性收集，并具有密集的收集间隔。

如果您对IVDR有进一步的问题或需要帮助实施相关要求，请联系我们。

诊断灵敏性检测盘

Order. no.	Panel	Product description
Panels for screening tests (acc. to Table 1, CTS):
CTS-HIV	Anti-HIV 1/2 panel	400 Anti-HIV 1 positive samples with • 40 non-B-subtypes (in each case at least 3 samples of the subtypes A, C, D, F, G, H, J, K, CRF01_AE, CRF02_AG, CRF06_cpx3, CRF11_cpx and group O) • 3 subtypes B • 357 Anti-HIV 1 samples unspecified 100 Anti-HIV 2 samples
CTS-HIV	30 HIV seroconversion panels	All seroconversion samples include established positives (they are p24 antigen and/or HIV RNA positive, established/detected by antibody screening (verification) tests and determined to be positive or undetermined by means of confirmatory tests), and include at least 40 early HIV seroconversion samples (these are p24 antigen and/or HIV RNA positive, not established/determined by antibody screening tests and determined as undetermined or negative using confirmatory tests)
CTS-HCV	Anti-HCV panel	400 Anti-HCV positive samples with • 21 of genotype 1 • 21 of genotype 2 • 21 of genotype 3 • 21 of genotype 4 • 21 of genotype 4 not subtype A • 5 of genotype 5 • 280 HCV samples unspecified
CTS-HCV	30 HCV seroconversion panels
CTS-HBsAg	HBsAg Panel	400 HBsAg positive samples with the different subtypes A1, A2, B1, B2, C1, C2, D1-7, E, F1-4, G, H
CTS-HBsAg	30 HBV seroconversion panels

诊断特异性检测盘

Order no.	Panels	Product description
CTS-BDP	Blood donor panels	5000 (screening test) or 1000 (rapid test) samples from unselected blood donors from at least 2 different European donation centers
CTS-HPP	Hospitalized patient panels	200 samples from patients suffering from severe illness and on medication
Cross-reaction panels More than 100 samples containing cross-reacting substances such as RF +, autoimmune antibodies, EBV, CMV, hepatitis samples, etc.
	General test panels	RF +, HAMA, pregnant women, multipara, hyper-IgM, hyper-IgG, dialysis patients, influenza vaccinated individuals, etc. 30 samples (in each case 3 samples)
	Blood bank marker panels	Anti-HIV 1, Anti-HCV, HBsAg, Anti-Syphilis etc. 15 samples (in each case 3 samples)
	Herpes panels	Anti-HSV 1, Anti-HSV 2, Anti-VZV, Anti-EBV, Anti-CMV 15 samples (in each case 3 samples)
	Hepatitis panels	Anti-HAV, Anti-HBs, Anti-HBc, Anti-HEV 12 samples (in each case 3 samples)
	Inhibition panels	Hemolytic, lipemic and icteric samples, low, mid and high concentration in addition to a negative control 36 samples (in each case 3 samples)
Serum / plasma equivalence panels In the case of products intended by the manufacturer for testing serum and plasma, the serum-plasma equivalence must be confirmed in the performance evaluation. Evidence must be provided from at least 50 donations (25 positive and 25 negative).
	25 negative matched sets	Serum, plasma (including all anticoagulants that might be used)

CS 核酸检测盘

CS筛查测试盘用于满足2017/746（IVDR）下D类设备的要求。有关IVDR的更多信息可以在这里找到。

如果您对IVDR有进一步的问题或需要帮助实施相关要求，请联系我们。

诊断灵敏性检测盘

Order no.	Panels	Product description
Panel for NAT testing (according to Table 2 CS): Panel for Genotype/Subtype Detection/Quantification Efficiency
NAT-HIV	NAT-HIV 1 Panel	10 samples of each subtype
NAT-HCV	NAT-HCV Panel	10 samples of each genotype
NAT-HBV	NAT-HBV Panel	10 samples of each subtype
Seroconversion panel
For qualitative PCR tests, diagnostic sensitivity must be evaluated on at least 10 seroconversion panels. They start with (a) negative collection(s) and have narrow collection intervals.
	10 HIV Seroconversion panel
	10 HCV Seroconversion panel
	10 HBV Seroconversion panel

诊断特异性检测盘

Order no.	Panels	Product description
NAT-BDP	Blood donor panel	500 samples of unselected blood donors (from at least 2 different European donation centers) for qualitative testing or 100 samples of unselected blood donors for quantitative testing.
NAT-HPP	Hospital-patients panel	200 samples from patients suffering from severe diseases and under medication.
Cross contamination panel To investigate possible carryover, at least five test series with alternating high positive and negative samples during robustness testing. The high positive samples contain samples with high viral load.
CCP-HIV	NAT-HIV Kreuzkontaminationspanel	5 HIV samples with high titer and 5 negative samples
CCP-HCV	NAT-HCV Kreuzkontaminationspanel	5 HCV samples with high titer and 5 negative samples
CCP-HBV	NAT-HBV Kreuzkontaminationspanel	5 HBV samples with high titer and 5 negative samples
Cross-Reactivity Panel By demonstrating an appropriate test design (e.g., sequence comparison) and/or testing on at least 10 specimens, Positive for human samples with related viral infection.
CRP-HIV	NAT-HIV Cross-Reactivity Panel	10 human retrovirus positive samples (e.g. HTLV)
CRP-HCV	NAT-HCV Cross-Reactivity Panel	10 human flavivirus positive samples (e.g. HGV, YFV).
CRP-HBV	NAT-HBV Cross-Reactivity Panel	10 human DNA virus positive samples
Serum Plasma Equivalent Panel For devices intended by the manufacturer to be tested in serum and plasma, serum-to-plasma correspondence must be demonstrated in the performance evaluation. Evidence must be provided on at least 50 donations (25 positive and 25 negative).
	25 negative Matched Sets	Serum, plasma (including any anticoagulants that may be used).

抑制血清盘

溶血、脂血和黄疸标本抑制血清盘用于检测诊断化验中因血清、血浆或全血标本中常见的干扰物质而产生的抑制效应。可提供不同的抑制血清盘规格： 5 份、10 份或更多份来自正常健康供血者的样本。我们可为您量身定制解决方案。

Order no.	Components (matrix: EDTA)	Concentration range	Quantity
IHH-005 (5 sample sets) IHH-010 (10 sample sets) or IHH-XXX (customized)	Hemolytic negative control Hemolytic plasma low* Hemolytic plasma medium* Hemolytic plasma high*	0.0 - 0.1 mg/dL 0.5 - 0.7 mg/dL 0.9 - 1.1 mg/dL 1.9 - 2.2 mg/dL	1.0 mL
	Components (matrix: CPD)
IHL-005 (5 sample sets) IHL-010 (10 sample sets) or IHL-XXX (customized)	Lipaemic negative control Lipaemic plasma low* Lipaemic plasma medium* Lipaemic plasma high*	50 - 199.9 mg/dL 200 - 399.9 mg/dL 400 - 800 mg/dL 400 - 800 mg/dL	1.0 mL
	Components (matrix: Serum)
IHI-005 (5 sample sets) IHI-010 (10 sample sets) or IHI-XXX (customized)	Icteric negative control Icteric plasma low Icteric plasma medium Icteric plasma high	to be defined 18 - 22 mg/dL 38 - 42 mg/dL 58 - 62 mg/dL	1.0 mL

* native samples ** spiked samples

干扰血清盘

我们的交叉反应血清盘可以选择各种潜在交叉反应物的特定组合。

干扰血清盘可提供不同的包装规格，可用于从健康供体采集一个（ABC-001）、五个（ABC-005）或十个（ABC-010）样本组。如果需要，我们还可以提供更大的包装单位（ABC-XXX）

我们为您量身定制解决方案。

Order no.	Product	Volumes
BTP-001 BTP-005 BTP-010 or BTP-XXX	General test panels • Rheumatoid factor • HAMA • Pregnant woman • Multipara • Hyper IgM, IgG • Dialysis patient • Recipient of an influenza vaccination (max. 6 months old)	1.0 mL
BBX-001 BBX-005 BBX-010 or BBX-XXX	Blood bank marker panels (3-pack, 6-pack, or made-to-order) • Anti-HIV 1 • Anti-HAV • Anti-HBs • Anti-HTLV I/II • Anti-HCV • Anti-Syphilis • Anti-HBc • HBsAg • Anti-CMV • Anti-Chagas … and more*	1.0 mL
HHV-001 HHV-005 HHV-010 or HHV-XXX	Herpes panels • Anti-HSV 1 • Anti-HSV 2 • Anti-VZV • Anti-EBV • Anti-CMV • Anti-HHV 6 • Anti-HHV 7 • Anti-HHV 8	1.0 mL
HEPP-001 HEPP-005 HEPP-010 or HEP-XXX	Hepatitis panels • Anti-HAV • HBsAg • Anti-HBs • Anti-HBc • Anti-HCV • Anti-HEV	1.0 mL
NPP-001 NPP-005 NPP-010 or NPP-XXX	Negative plasma panels Can be used to check the specificity of tests • Anti-HIV • Anti-HBs/HBsAg • Anti-HCV • Anti-CMV • Anti-HTLV I/II • Anti-Syphilis … and more* According to the regulatory requirements up to 5000 individuals	1.0 mL
* or contract production

其他的血清盘

BIOMEX 还提供多种其他类型的血清盘。如果您需要的特定血清盘未在此列出，请联系我们。我们很乐意为您量身定制

Order no.	Product	Panel member	Member volumes	Additional information
MSP-HIV-001	Anti-HIV Mixed subtype panel	22	0.5 mL	Incl. HIV 1, HIV 1 gO, HIV 2 and 2 x neg.
MTP-HTLV-001	Anti-HTLV I/II mixed titer panel	15	1.0 mL	HTLV I/II pos., neg. and unclear
VFP-HCV-001	HCV verification panel	10	0.5 mL	Sampling Feb 98 – Mar 98
NP-RUB-001	Rubella negative panel	100	0.5 mL
LPS-HCVAg-001	HCV Ag linearity panel min	50	1.0 mL	HCV Ag range: 4.0 - 49.941 fmol/L
LPL-HCVAg-001	HCV Ag linearity panel max	100	1.0 mL	HCV Ag range: 4.0 - 97.243 fmol/L
VAP-HCVAg-001	HCV Ag validation panel low	20	1.0 mL	HCV Ag range: 4.0 - 1,645.94 fmol/L
VAP-HCVAg-002	HCV Ag validation panel medium	20	1.0 mL	HCV Ag range: 430 - 18,537 fmol/L
VAP-HCVAg-003	HCV Ag validation panel high	20	1.0 mL	HCV Ag range: 1,136 - 80,197 fmol/L

质控发放检测盘

质控发放检测盘（血清和血浆）

通过我们的供体收集中心以及与实验室机构的合作，BIOMEX 可以提供几乎所有参数的不同范围的现货产品。

质控发放检测盘可根据所需的范围和参数量身定制。

阳性 – 低、中、高范围
阴性 – 无分析物、无病毒、无特异性抗体
临界值 – 从检测限界到临床决策点的范围值

另请注意子页面，其中展示了我们广泛具有阳性感染标志物的人体生物样本。

或者借此机会直接在我们的数据库中搜索您想要的样品：

ZeptoMetrix 盘

北美公司 ZeptoMetrix® 是高质量血清转换盘的市场领导者之一，其产品性价比非常高。血清转换盘有助于诊断制造商、研究人员和临床实验室开发或评估新的检测方法，因此是质量控制和质量保证不可或缺的工具。血清转换试剂盒包含明确的感染标志物以及广泛的样本数据，可用于比较和分析。

BIOMEX 在欧洲独家销售 ZeptoMetrix® 产品组合。

Order no.	Marker	Member	Member volumes
EBV9097	EBV	14	1.0 mL
HBV10231	HBV	16	1.0 mL
HBV10232	HBV	6	1.0 mL
HBV11000	HBV	9	1.0 mL
HBV11001	HBV	8	1.0 mL
HBV11002	HBV	6	1.0 mL
HBV11003	HBV	8	1.0 mL
HBV11004	HBV	8	1.0 mL
HBV11005	HBV	14	1.0 mL
HBV11006	HBV	17	1.0 mL
HBV11007	HBV	14	1.0 mL
HBV11008	HBV	18	1.0 mL
HBV11009	HBV	23	1.0 mL
HBV11010	HBV	18	1.0 mL
HBV11011	HBV	14	1.0 mL
HBV11012	HBV	6	1.0 mL
HBV11013	HBV	35	1.0 mL
HBV11014	HBV	12	1.0 mL
HBV11015	HBV	14	1.0 mL
HBV11016	HBV	10	1.0 mL
HBV11017	HBV	14	1.0 mL
HBV11024	HBV	14	1.0 mL
HBV11026	HBV	16	1.0 mL
HBV11027	HBV	14	1.0 mL
HBV11028	HBV	10	1.0 mL
HBV11029	HBV	13	1.0 mL
HBV11031	HBV	16	1.0 mL
HBV11052	HBV	13	1.0 mL
HBV11056	HBV	11	1.0 mL
HBV11058	HBV	8	1.0 mL
HBV11059	HBV	9	1.0 mL
HBV11062	HBV	12	1.0 mL
HBV11064	HBV	9	1.0 mL
HBV11069	HBV	15	1.0 mL
HBV6271	HBV	5	1.0 mL
HBV6272	HBV	25	1.0 mL
HBV6273	HBV	6	1.0 mL
HBV6274	HBV	7	1.0 mL
HBV6275	HBV	7	1.0 mL
HBV6276	HBV	8	1.0 mL
HBV6277	HBV	11	1.0 mL
HBV6278	HBV	11	1.0 mL
HBV6279	HBV	7	1.0 mL
HBV6280	HBV	5	1.0 mL
HBV6281	HBV	12	1.0 mL
HBV6282	HBV	14	1.0 mL
HBV6283	HBV	11	1.0 mL
HBV6284	HBV	19	1.0 mL
HBV6285	HBV	16	1.0 mL
HBV6286	HBV	9	1.0 mL
HBV6287	HBV	11	1.0 mL
HBV6288	HBV	9	1.0 mL
HBV6289	HBV	10	1.0 mL
HBV6290	HBV	12	1.0 mL
HBV6291	HBV	8	1.0 mL
HBV6292	HBV	12	1.0 mL
HBV6293	HBV	7	1.0 mL
HBV9072	HBV	18	1.0 mL
HBV9073	HBV	16	1.0 mL
HBV9074	HBV	20	1.0 mL
HBV9092	HBV	37	1.0 mL
HBV9093	HBV	31	1.0 mL
HBV9098	HBV	17	1.0 mL
HBV9099	HBV	20	1.0 mL
HCV10000	HCV PCR	10	1.0 mL
HCV10002	HCV PCR	7	1.0 mL
HCV10003	HCV PCR	13	1.0 mL
HCV10004	HCV PCR	6	1.0 mL
HCV10007	HCV PCR	11	1.0 mL
HCV10008	HCV PCR	10	1.0 mL
HCV10009	HCV PCR	6	1.0 mL
HCV10010	HCV PCR	7	1.0 mL
HCV10011	HCV PCR	13	1.0 mL
HCV10012	HCV PCR	13	1.0 mL
HCV10013	HCV PCR	10	1.0 mL
HCV10014	HCV PCR	4	1.0 mL
HCV10016	HCV PCR	12	1.0 mL
HCV10017	HCV PCR	16	1.0 mL
HCV10019	HCV PCR	8	1.0 mL
HCV10020	HCV PCR	13	1.0 mL
HCV10021	HCV PCR	14	1.0 mL
HCV10022	HCV PCR	11	1.0 mL
HCV10023	HCV PCR	21	1.0 mL
HCV10024	HCV PCR	8	1.0 mL
HCV10025	HCV PCR	11	1.0 mL
HCV10026	HCV PCR	12	1.0 mL
HCV10027	HCV PCR	8	1.0 mL
HCV10028	HCV PCR	7	1.0 mL
HCV10029	HCV PCR	16	1.0 mL
HCV10030	HCV PCR	8	1.0 mL
HCV10032	HCV PCR	16	1.0 mL
HCV10033	HCV PCR	10	1.0 mL
HCV10036	HCV PCR	13	1.0 mL
HCV10043	HCV PCR	10	1.0 mL
HCV10044	HCV PCR	4	1.0 mL
HCV10045	HCV PCR	5	1.0 mL
HCV10050	HCV PCR	15	1.0 mL
HCV10051	HCV PCR	14	1.0 mL
HCV10052	HCV PCR	12	1.0 mL
HCV10057	HCV	7	1.0 mL
HCV10058	HCV	7	1.0 mL
HCV10062	HCV	8	1.0 mL
HCV10071	HCV	7	1.0 mL
HCV10165	HCV	9	1.0 mL
HCV10185	HCV	5	1.0 mL
HCV10235	HCV Pre/Post	5	1.0 mL
HCV6215	HCV	4	1.0 mL
HCV6216	HCV	7	1.0 mL
HCV6217	HCV	5	1.0 mL
HCV6218	HCV	8	1.0 mL
HCV6219	HCV	14	1.0 mL
HCV6220	HCV	6	1.0 mL
HCV6221	HCV	8	1.0 mL
HCV6222	HCV	8	1.0 mL
HCV6223	HCV	22	1.0 mL
HCV6224	HCV	6	1.0 mL
HCV6225	HCV	19	1.0 mL
HCV6226	HCV	12	1.0 mL
HCV6227	HCV	7	1.0 mL
HCV6228	HCV	12	1.0 mL
HCV6229	HCV	8	1.0 mL
HCV9041	HCV	8	1.0 mL
HCV9042	HCV	6	1.0 mL
HCV9043	HCV	6	1.0 mL
HCV9044	HCV	6	1.0 mL
HCV9045	HCV	8	1.0 mL
HCV9046	HCV	5	1.0 mL
HCV9047	HCV	10	1.0 mL
HCV9048	HCV	8	1.0 mL
HCV9049	HCV	5	1.0 mL
HCV9050	HCV	13	1.0 mL
HCV9054	HCV	10	1.0 mL
HCV9055	HCV	11	1.0 mL
HCV9057	HCV	11	1.0 mL
HCV9058	HCV	5	1.0 mL
HCV9094	HCV	5	1.0 mL
HCV9095	HCV	5	1.0 mL
HIV10234	HIV Pre/Post	3	1.0 mL
HIV12007	HIV	9	1.0 mL
HIV12008	HIV	13	1.0 mL
HIV6244	HIV	13	1.0 mL
HIV6248	HIV	7	1.0 mL
HIV9011	HIV	11	1.0 mL
HIV9012	HIV	8	1.0 mL
HIV9013	HIV	7	1.0 mL
HIV9014	HIV	5	1.0 mL
HIV9015	HIV	8	1.0 mL
HIV9016	HIV	10	1.0 mL
HIV9018	HIV	11	1.0 mL
HIV9019	HIV	3	1.0 mL
HIV9020	HIV	22	1.0 mL
HIV9021	HIV	17	1.0 mL
HIV9022	HIV	9	1.0 mL
HIV9023	HIV	22	1.0 mL
HIV9024	HIV	12	1.0 mL
HIV9025	HIV	12	1.0 mL
HIV9026	HIV	7	1.0 mL
HIV9028	HIV	7	1.0 mL
HIV9029	HIV	12	1.0 mL
HIV9030	HIV	16	1.0 mL
HIV9031	HIV	19	1.0 mL
HIV9032	HIV	10	1.0 mL
HIV9033	HIV	16	1.0 mL
HIV9034	HIV	13	1.0 mL
HIV9075	HIV	5	1.0 mL
HIV9076	HIV	9	1.0 mL
HIV9077	HIV	27	1.0 mL
HIV9078	HIV	5	1.0 mL
HIV9079	HIV	25	1.0 mL
HIV9081	HIV	4	1.0 mL
HIV9082	HIV	4	1.0 mL
HIV9084	HIV	4	1.0 mL
HIV9089	HIV	6	1.0 mL
HIV9096	HIV	6	1.0 mL